Patient-reported outcomes from the phase III, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 Study of pembrolizumab plus concurrent chemoradiotherapy among patients with high-risk, locally advanced cervical cancer.

Autor: Randall, Leslie1 (AUTHOR), Sukhin, Vladyslav2 (AUTHOR), Colombo, Nicoletta3 (AUTHOR), Korach, Jacob4 (AUTHOR), Matsumoto, Takashi5 (AUTHOR), Lalondrelle, Susan6 (AUTHOR), Vizkeleti, Julia7 (AUTHOR), Samouelian, Vanessa8 (AUTHOR), Salani, Ritu9 (AUTHOR), Salman, Pamela10 (AUTHOR), Nogueira-Rodrigues, Angelica11 (AUTHOR), Ayhan, Ali12 (AUTHOR), Frentzas, Sophia13 (AUTHOR), Cueva, Juan14 (AUTHOR), Kim, Yong-Man15 (AUTHOR), Petru, Edgar16 (AUTHOR), Milla, Dency Pilar17 (AUTHOR), Sehouli, Jalid18 (AUTHOR), Saevets, Valeriya19 (AUTHOR), Yamada, Karin20 (AUTHOR)
Zdroj: Gynecologic Oncology. 2024 Supplement 1, Vol. 190, pS9-S9. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: